M. Steckel

发表

An RNA interference screen ide.jpgies Inhibitor of Apoptosis Protein 2 as a regulator of innate immune signalling in Drosophila

Michael Boutros, M. Boutros, David Kuttenkeuler, 2005, EMBO reports.

Functional Genomics in Pharmaceutical Drug Discovery.

B. Nicke, M. Steckel, R. Adams, 2016, Handbook of experimental pharmacology.

Rapid Development of Real-Time RT-PCR Assays Using Universal ProbeLibrary : Applications for Dissecting Signaling Pathways by RNA Interference

M. Boutros, M. Steckel, 2005 .

The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer

Julian Downward, Axel Behrens, Phillip East, 2012, Cell.

Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.

P. Chow, A. Haegebarth, W. Han, 2019, Journal of hepatology.

TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.

Ki-Young Lee, Nobuyuki Tanaka, Shizuo Akira, 2005, Genes & development.

Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death

P. Steigemann, A. Schlicker, Sven Christian, 2017, Cell Death and Disease.

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia

E. Nevedomskaya, A. Haegebarth, M. Steckel, 2019, Journal of Hematology & Oncology.

Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies

Julian Downward, Gavin Kelly, Miriam Molina-Arcas, 2012, Cell Research.

Identification of Small Molecules that Modulate Mutant p53 Condensation

A. Kamburov, P. Steigemann, M. Lange, 2020, iScience.

Abstract 4163: Determination of synthetic lethal interactions in KRAS oncogene dependent cancer cells reveals novel therapeutic targeting strategies

D. Hancock, J. Downward, M. Steckel, 2012 .